Page last updated: 2024-09-02

dihydroergocryptine and Parkinson Disease

dihydroergocryptine has been researched along with Parkinson Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lee, MR	1
Albanese, A; Colosimo, C	1
Gasser, T; Pöpperl, G; Ruzicka, E; Schwarz, J; Storch, A; Tatsch, K	1
Magnani, P; Mailland, E; Ottillinger, B	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1

Reviews

3 review(s) available for dihydroergocryptine and Parkinson Disease

Article	Year
DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Dihydroergocryptine; Dopamine Agonists; Ergot Alkaloids; Humans; Parkinson Disease; Randomized Controlled Trials as Topic	2002
Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists. Acta neurologica Scandinavica, 2003, Volume: 107, Issue:5 Topics: Clinical Trials as Topic; Dihydroergocryptine; Dopamine Agonists; Humans; Parkinson Disease; Treatment Outcome	2003
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005

Trials

2 trial(s) available for dihydroergocryptine and Parkinson Disease

Article	Year
Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT. Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:8 Topics: Adolescent; Aged; Caudate Nucleus; Dihydroergocryptine; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes	2004
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease. Arzneimittel-Forschung, 2004, Volume: 54, Issue:10 Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor	2004

Article

Year

Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.

Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:8

Topics: Adolescent; Aged; Caudate Nucleus; Dihydroergocryptine; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes

2004

Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.

Arzneimittel-Forschung, 2004, Volume: 54, Issue:10

Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor

2004

Other Studies

1 other study(ies) available for dihydroergocryptine and Parkinson Disease

Article	Year
The history of ergot of rye (Claviceps purpurea) III: 1940-80. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1 Topics: Bromocriptine; Claviceps; Dihydroergocryptine; Ergot Alkaloids; History, 20th Century; Humans; Lysergic Acid Diethylamide; Parkinson Disease; Prolactinoma; Receptors, Dopamine; Schizophrenia; Scotland; Secale	2010